Clinical Study
Efficacy and Mechanism of Preoperative Simvastatin Therapy on Myocardial Protection after Extracorporeal Circulation
Table 3
Patients’ postoperative course.
(a) |
| Group | Duration of assisted respiration | 24 Hr average urine volume | 24 Hr total drainage | Duration of staying in ICU | EF 10 days after operation | (h) | (ml/h) | (ml) | (h) | (%) |
| Simvastatin group | | | | | | Control group | | | | | | | −2.208 | 1.761 | −0.994 | −1.152 | 2.290 | | 0.030 | 0.081 | 0.322 | 0.252 | 0.024 |
|
|
(b) |
| Group | Total cholesterol | Triglyceride | Low-density lipoprotein | High-density lipoprotein | (mmol/L) | (mmol/L) | (mmol/L) | (mmol/L) |
| Simvastatin group | | | | | Control group | | | | | | −1.057 | −1.876 | −1.224 | −1.906 | | 0.293 | 0.063 | 0.224 | 0.059 |
|
|
compared with control group. EF: ejection fraction; ICU: intensive care unit.
|